Latest articles by Luzi Ann Javier
11 articles written by this author
Tesla topples Meta as fifth largest stock on Russell indexes. Will your stock move?
Tesla topples Meta as fifth largest stock on Russell indexes as part of rebalancing.

Tesla shares climb 12% as Musks says EV demand still strong
Tesla shares climbed as Musk said EV demand remains strong, signaling stock’s resilience despite recession fears.

Revlon shares almost doubled. Time for an exit?
Why Revlon shares’ 120% surge provides a good opportunity to sell stake in the bankrupt company.

Ford plans to recall 3 million cars; time to sell?
Ford recalls 3 million vehicles to fix a defect. Is it time to sell?

Bitcoin’s price slump fuels massive selloff in MicroStrategy, Coinbase
Bitcoin’s price slump fuels massive selloff in MicroStrategy, Coinbase shares. Is it time to buy or sell?

About one-third of hedge funds have jumped into crypto
Crypto market attracts 38% of hedge funds, signaling wider acceptance, PwC survey shows

Lululemon, 2 other apparel stocks to buy during a global economic downturn
Analysts rate these three apparel stocks as buys and say they could fare better than peers that are selling goods at discount amid an economic downturn.

Target shares sink 3.9% as profit outlook dims. Is it time to buy or sell?
Target shares have fallen 32% this year, and it just lowered its profit outlook. Time to sell?

Twitter shares fall 2.7% after Musk threatens to end the takeover deal. Is it time to sell?
Musk threatens to call off his Twitter takeover deal over spam, fake account data. Here’s what that means for Twitter, Tesla shareholders.

Novavax shares fall 20% on vaccine trial concerns. Time to sell?
FDA raises concern over four cases of heart inflammation found during the Novavax COVID vaccine trial, adding another layer of uncertainty to the company’s sales outlook.
